Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

Children and teenagers could benefit from new asthma therapy

October 6, 2022
admin
Children aged 6-17 could benefit from tiotropium Respimat if the drug is added to maintenance asthma therapy, according to findings from a Phase 3 clinical trial.

New research has shown that doctors are frequently inaccurate when predicting how long those living with terminal illnesses will survive.

October 6, 2022
admin
Researchers at the Marie Curie Palliative Care Research Department at UCL combined the results of previous studies, reviewing 4,642 records of clinicians' predictions regarding survival of patients approaching the ends of their lives. The study revealed wide variation in errors, ranging from an underestimate of 86 days to an overestimate of 93 days.

Scottish Medicines Consortium recommends new schizophrenia treatment

October 6, 2022
admin
The Scottish Medicines Consortium (SMC) has recommended the use of paliperidone palmitate 3-monthly injection (Trevicta) for use in NHS Scotland without restriction for the maintenance treatment of schizophrenia.

Diabetes prevalence soars to 3.8 million people in England

October 6, 2022
admin
One in four people with diabetes, an estimated 940,000, are unaware of their condition according to a new Diabetes Prevalence Model, produced by the Public Health England (PHE) National Cardiovascular Intelligence Network (NCVIN).

Orphan drug designation granted to nintedanib for treatment of systemic sclerosis

October 6, 2022
admin
The European Commission (EC) and US Food and Drug Administration (FDA) have granted Orphan Drug Designation to nintedanib for the treatment of systemic sclerosis (SSc), including the associated interstitial lung disease (SSc-ILD). 

New statistics on drug poisoning released by Office for National Statistics

October 6, 2022
admin
Drug poisoning is the fourth most common cause of death in people aged 15-49, new data released by the Office for National Statistics have revealed.

Artificial intelligence could improve diagnostic power of lung function tests

October 6, 2022
admin
Artificial intelligence could improve the interpretation of lung function tests for the diagnosis of long-term lung diseases, according to a new study.

Data supports use of edoxaban in patients with atrial fibrillation undergoing cardioversion

October 6, 2022
admin
Results presented at ESC Congress 2016 in Rome, and published online in The Lancet support the use of edoxaban (Lixiana) in patients with atrial fibrillation undergoing cardioversion, it has been announced.

New data to support edoxaban in patients with atrial fibrillation undergoing cardioversion

October 6, 2022
admin
Results from the global phase 3b ENSURE-AF study of 2,199 patients with non-valvular atrial fibrillation (NVAF) undergoing electrical cardioversion were presented recently at the ESC Congress 2016 in Rome, and published online in The Lancet. 

Evidence suggests Vitamin D can reduce asthma attacks

October 6, 2022
admin
A new Cochrane Review published in the Cochrane Library has found evidence from randomized trials that taking an oral vitamin D supplement in addition to standard asthma medication is likely to reduce severe asthma attacks.

Study opens door to targeted treatments for oesophageal cancer

October 6, 2022
admin
Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments tailored to patients' disease for the first time.

New clinical review helps GP practices to identify and monitor high-risk patients

October 6, 2022
admin
A review at a GP practice of patients potentially at high-risk of certain conditions saw more than 500 patients added to their QOF clinical register, Interface Clinical Services, which conducted the review, has revealed.

New technique developed to identify children at risk of hospitalisation following coughs and respiratory tract infections

October 6, 2022
admin
Researchers have developed a technique that will help GPs identify which children with coughs and respiratory tract infections (RTIs) are most at risk of future hospitalisation.

New project could see more people diagnosed with coeliac disease

October 6, 2022
admin
Coeliac UK, the national charity for people with coeliac disease, has announced the publication of an innovative project using community pharmacies to assist in finding patients with undiagnosed coeliac disease. The findings indicate that if the approach was embraced by the NHS, it could speed up diagnosis and lift low diagnosis rates by targeting those suffering the most common symptoms of coeliac disease for testing.

Community pharmacies can improve diagnosis of coeliac disease, pilot study reveals

October 6, 2022
admin
Using community pharmacies to assist in finding patients with undiagnosed coeliac disease could help improve detection and diagnosis, a pilot study by Coeliac UK has revealed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy